These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5549140)

  • 41. Lipid metabolism in children with chronic hepatitis C, A preliminary report.
    Wisniewska-Ligier M; Wozniakowska-Gesicka T; Kups J; Sulat-Syncerek D
    Hepatogastroenterology; 2006; 53(72):887-91. PubMed ID: 17153447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.
    Promrat K; Lutchman G; Uwaifo GI; Freedman RJ; Soza A; Heller T; Doo E; Ghany M; Premkumar A; Park Y; Liang TJ; Yanovski JA; Kleiner DE; Hoofnagle JH
    Hepatology; 2004 Jan; 39(1):188-96. PubMed ID: 14752837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between periodontitis and hepatic condition in Japanese women.
    Saito T; Shimazaki Y; Koga T; Tsuzuki M; Ohshima A
    J Int Acad Periodontol; 2006 Jul; 8(3):89-95. PubMed ID: 16865998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of riboflavin-2',3',4',5',-tetrabutyrate on total serum cholesterol and beta-lipoprotein contents].
    Takenaka T; Hara S
    Iryo; 1972 Feb; 26(2):153-6. PubMed ID: 5023624
    [No Abstract]   [Full Text] [Related]  

  • 45. [Optimization of diet therapy in patients with gallstones complicated with obesity and impaired glucose tolerance].
    Kurbanov SK
    Vopr Pitan; 2003; 72(5):22-4. PubMed ID: 14619611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.
    Perseghin G; Bonfanti R; Magni S; Lattuada G; De Cobelli F; Canu T; Esposito A; Scifo P; Ntali G; Costantino F; Bosio L; Ragogna F; Del Maschio A; Chiumello G; Luzi L
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E697-703. PubMed ID: 16684857
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonalcoholic fatty liver disease and OGTT.
    Uygur-Bayramiçli O; Sargin M
    J Clin Gastroenterol; 2008 Feb; 42(2):219. PubMed ID: 18209601
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
    Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
    Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Nonalcoholic steatohepatitis].
    Dancygier H
    Dtsch Med Wochenschr; 2001 Aug; 126(33):930. PubMed ID: 11550669
    [No Abstract]   [Full Text] [Related]  

  • 50. [Should we do a liver puncture biopsy in patients with chronic "unexplained" cytolyses?].
    De Lédinghen V
    Gastroenterol Clin Biol; 2002; 26(8-9):724-7. PubMed ID: 12434076
    [No Abstract]   [Full Text] [Related]  

  • 51. Electron microscopy in the diagnostics of liver diseases.
    Satler J
    Acta Hepatosplenol; 1968; 15(2):72-7. PubMed ID: 5670008
    [No Abstract]   [Full Text] [Related]  

  • 52. Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis.
    Ayala I; Castillo AM; Adánez G; Fernández-Rufete A; Pérez BG; Castells MT
    Exp Biol Med (Maywood); 2009 Jan; 234(1):10-6. PubMed ID: 18997102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients.
    Ghods AJ; Milanian I; Arghani H; Ghadiri G
    Transplant Proc; 1995 Oct; 27(5):2579-80. PubMed ID: 7482835
    [No Abstract]   [Full Text] [Related]  

  • 54. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical experiences on the anti-dyslipidemic effect of a new sulfomucopolysaccharide of pancreatic origin].
    Castello S
    Clin Ter; 1971 Aug; 58(4):323-34. PubMed ID: 4258171
    [No Abstract]   [Full Text] [Related]  

  • 56. [Serial biochemical and histological studies on fatty liver in obese patients].
    Ueno T; Nagata E; Sakisaka S; Kumashiro R; Miura T; Gondo K; Akashi T; Matsuzaki T; Wada T; Kuwaki T
    Nihon Shokakibyo Gakkai Zasshi; 1985 Nov; 82(11):2782-9. PubMed ID: 4087483
    [No Abstract]   [Full Text] [Related]  

  • 57. [Relationship between serum cholesterol level and liver function tests in male workers in an urban area].
    Takashima Y; Suzuki K; Hitosugi M; Takata T
    Sangyo Igaku; 1990 Sep; 32(5):352-3. PubMed ID: 2273586
    [No Abstract]   [Full Text] [Related]  

  • 58. Elevation of collagenase activity in fatty liver.
    Watanabe A; Kobayashi M
    Hiroshima J Med Sci; 1987 Dec; 36(4):417-9. PubMed ID: 2834308
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapeutic agents for lipid metabolism disorders--with special reference to fatty liver].
    Okabe K; Fujisawa K; Takahashi T
    Nihon Rinsho; 1970 Mar; 28():Suppl:700-3. PubMed ID: 5465060
    [No Abstract]   [Full Text] [Related]  

  • 60. [The treatment of meteorism with Pancreoflat].
    Dziuba K
    Med Klin; 1967 Jan; 62(1):20-3. PubMed ID: 5340251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.